Abstract
The administration of cells as therapeutic agents has emerged as a novel approach to complement the use of small molecule drugs and other biologics for the treatment of numerous conditions. Although the use of cells for structural and/or functional tissue repair and regeneration provides new avenues to address increasingly complex disease processes, it also faces numerous challenges related to efficacy, safety, and translational potential. Recent advances in nanotechnology-driven cell therapies have the potential to overcome many of these issues through precise modulation of cellular behavior. Here, we describe several approaches that illustrate the use of different nanotechnologies for the optimization of cell therapies and discuss some of the obstacles that need to be overcome to allow for the widespread implementation of nanotechnology-based cell therapies in regenerative medicine.
Graphical abstract
Similar content being viewed by others
References
Wang M-L. The modern pharmaceutical industry: history, current position and challenges. Global Health Partnerships: The Pharmaceutical Industry and BRICA. London: Palgrave Macmillan UK; 2009. p. 33-80.
Mason C, Brindley DA, Culme-Seymour EJ, Davie NL. Cell therapy industry: billion dollar global business with unlimited potential. Regen Med. 2011;6(3):265–72.
Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med. 2013;5(179):179ps7.
Au P, Hursh DA, Lim A, Moos MC Jr, Oh SS, Schneider BS, et al. FDA oversight of cell therapy clinical trials. Sci Transl Med. 2012;4(149):149fs31.
Towards advanced cell therapies. Nature Biomedical Engineering. 2018;2(6):339-40.
Science N. TC. National nanotechnology initiative, research and development leading to a revolution in technology and industry. A supplement to the President’s FY 2006 budget. 2005.
Heath JR. Nanotechnologies for biomedical science and translational medicine. Proc Natl Acad Sci U S A. 2015;112(47):14436–43.
Mount NM, Ward SJ, Kefalas P, Hyllner J. Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370(1680):20150017.
Sanchez A, Schimmang T, Garcia-Sancho J. Cell and tissue therapy in regenerative medicine. Adv Exp Med Biol. 2012;741:89–102.
Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27(4):523–31.
Dreyer DR, Park S, Bielawski CW, Ruoff RS. The chemistry of graphene oxide. Chem Soc Rev. 2010;39(1):228–40.
Jing G, Li K, Sun F, Niu J, Zhu R, Qian Y, et al. Layer-number-dependent effects of graphene oxide on the pluripotency of mouse embryonic stem cells through the regulation of the interaction between the extracellular matrix and integrins. Int J Nanomedicine. 2021;16:3819–32.
Yang D, Li T, Xu M, Gao F, Yang J, Yang Z, et al. Graphene oxide promotes the differentiation of mouse embryonic stem cells to dopamine neurons. Nanomedicine (London). 2014;9(16):2445–55.
Garcia-Alegria E, Iliut M, Stefanska M, Silva C, Heeg S, Kimber SJ, et al. Graphene oxide promotes embryonic stem cell differentiation to haematopoietic lineage. Sci Rep. 2016;6:25917.
Park SY, Park J, Sim SH, Sung MG, Kim KS, Hong BH, et al. Enhanced differentiation of human neural stem cells into neurons on graphene. Adv Mater. 2011;23(36):H263–7.
Galipeau J, Sensebe L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–33.
Halim A, Luo Q, Ju Y, Song G. A mini review focused on the recent applications of graphene oxide in stem cell growth and differentiation. Nanomaterials (Basel). 2018;8(9).
Nayak TR, Andersen H, Makam VS, Khaw C, Bae S, Xu X, et al. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano. 2011;5(6):4670–8.
Lee WC, Lim CH, Shi H, Tang LA, Wang Y, Lim CT, et al. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano. 2011;5(9):7334–41.
Lee WC, Lim CH. Kenry, Su C, Loh KP, Lim CT. Cell-assembled graphene biocomposite for enhanced chondrogenic differentiation. Small. 2015;11(8):963–9.
Kim J, Park S, Kim YJ, Jeon CS, Lim KT, Seonwoo H, et al. Monolayer graphene-directed growth and neuronal differentiation of mesenchymal stem cells. J Biomed Nanotechnol. 2015;11(11):2024–33.
Guo W, Wang S, Yu X, Qiu J, Li J, Tang W, et al. Construction of a 3D rGO-collagen hybrid scaffold for enhancement of the neural differentiation of mesenchymal stem cells. Nanoscale. 2016;8(4):1897–904.
Vining KH, Mooney DJ. Mechanical forces direct stem cell behaviour in development and regeneration. Nat Rev Mol Cell Biol. 2017;18(12):728–42.
Kenry LCT. Nanofiber technology: current status and emerging developments. Prog Polym Sci. 2017;70:1–17.
Bagher Z, Azami M, Ebrahimi-Barough S, Mirzadeh H, Solouk A, Soleimani M, et al. Differentiation of Wharton’s jelly-derived mesenchymal stem cells into motor neuron-like cells on three-dimensional collagen-grafted nanofibers. Mol Neurobiol. 2016;53(4):2397–408.
Sankar D, Mony U, Rangasamy J. Combinatorial effect of plasma treatment, fiber alignment and fiber scale of poly (epsilon-caprolactone)/collagen multiscale fibers in inducing tenogenesis in non-tenogenic media. Mater Sci Eng C Mater Biol Appl. 2021;127:112206.
Sridharan D, Palaniappan A, Blackstone BN, Dougherty JA, Kumar N, Seshagiri PB, et al. In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold. Mater Sci Eng C Mater Biol Appl. 2021;118:111354.
Jeon BM, Yeon GB, Goo HG, Lee KE, Kim DS. PVDF nanofiber scaffold coated with a vitronectin peptide facilitates the neural differentiation of human embryonic stem cells. Dev Reprod. 2020;24(2):135–47.
Abazari MF, Zare Karizi S, Hajati-Birgani N, Norouzi S, Khazeni Z, Hashemi J, et al. PHBV nanofibers promotes insulin-producing cells differentiation of human induced pluripotent stem cells. Gene. 2021;768:145333.
Cui H, Cheetham AG, Pashuck ET, Stupp SI. Amino acid sequence in constitutionally isomeric tetrapeptide amphiphiles dictates architecture of one-dimensional nanostructures. J Am Chem Soc. 2014;136(35):12461–8.
Sleep E, Cosgrove BD, McClendon MT, Preslar AT, Chen CH, Sangji MH, et al. Injectable biomimetic liquid crystalline scaffolds enhance muscle stem cell transplantation. Proc Natl Acad Sci. 2017;114(38):E7919.
Berns EJ, Sur S, Pan L, Goldberger JE, Suresh S, Zhang S, et al. Aligned neurite outgrowth and directed cell migration in self-assembled monodomain gels. Biomaterials. 2014;35(1):185–95.
Park SJ, Kim S, Kim SY, Jeon NL, Song JM, Won C, et al. Highly efficient and rapid neural differentiation of mouse embryonic stem cells based on retinoic acid encapsulated porous nanoparticle. ACS Appl Mater Interfaces. 2017;9(40):34634–40.
Seo HI, Cho AN, Jang J, Kim DW, Cho SW, Chung BG. Thermo-responsive polymeric nanoparticles for enhancing neuronal differentiation of human induced pluripotent stem cells. Nanomedicine. 2015;11(7):1861–9.
Yamoah MA, Moshref M, Sharma J, Chen WC, Ledford HA, Lee JH, et al. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles. Int J Nanomedicine. 2018;13:6073–8.
Li X, Tzeng SY, Liu X, Tammia M, Cheng YH, Rolfe A, et al. Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain. Biomaterials. 2016;84:157–66.
Saraiva C, Paiva J, Santos T, Ferreira L, Bernardino L. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease. J Control Release. 2016;235:291–305.
Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132(4):645–60.
Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12(4):399–408.
Zhang R, Li Y, Hu B, Lu Z, Zhang J, Zhang X. Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer’s disease therapy. Adv Mater. 2016;28(30):6345–52.
Karimi S, Bagher Z, Najmoddin N, Simorgh S, Pezeshki-Modaress M. Alginate-magnetic short nanofibers 3D composite hydrogel enhances the encapsulated human olfactory mucosa stem cells bioactivity for potential nerve regeneration application. Int J Biol Macromol. 2021;167:796–806.
Orza A, Soritau O, Olenic L, Diudea M, Florea A, Rus Ciuca D, et al. Electrically conductive gold-coated collagen nanofibers for placental-derived mesenchymal stem cells enhanced differentiation and proliferation. ACS Nano. 2011;5(6):4490–503.
Pourpirali R, Mahmoudnezhad A, Oroojalian F, Zarghami N, Pilehvar Y. Prolonged proliferation and delayed senescence of the adipose-derived stem cells grown on the electrospun composite nanofiber co-encapsulated with TiO2 nanoparticles and metformin-loaded mesoporous silica nanoparticles. Int J Pharm. 2021;604:120733.
Webber MJ, Tongers J, Newcomb CJ, Marquardt K-T, Bauersachs J, Losordo DW, et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci. 2011;108(33):13438–43.
Usmani S, Franceschi Biagioni A, Medelin M, Scaini D, Casani R, Aurand ER, et al. Functional rewiring across spinal injuries via biomimetic nanofiber scaffolds. Proc Natl Acad Sci U S A. 2020;117(41):25212–8.
Wu X, He L, Li W, Li H, Wong WM, Ramakrishna S, et al. Functional self-assembling peptide nanofiber hydrogel for peripheral nerve regeneration. Regen Biomater. 2017;4(1):21–30.
Yang R, Yan Y, Wu Z, Wei Y, Song H, Zhu L, et al. Resveratrol-loaded titania nanotube coatings promote osteogenesis and inhibit inflammation through reducing the reactive oxygen species production via regulation of NF-κB signaling pathway. Mater Sci Eng C Mater Biol Appl. 2021;131:112513.
Uyanik O, Pekkoc-Uyanik KC, Findik S, Avci A, Altuntas Z. Prevention of peritendinous adhesions with electrospun poly (lactic acid-co-glycolic acid) (PLGA) bioabsorbable nanofiber: An experimental study. Colloids Surf B: Biointerfaces. 2022;209(Pt 2):112181.
Kim JE, Lee J, Jang M, Kwak MH, Go J, Kho EK, et al. Accelerated healing of cutaneous wounds using phytochemically stabilized gold nanoparticle deposited hydrocolloid membranes. Biomater Sci. 2015;3(3):509–19.
McCauley MD, Vitale F, Yan JS, Young CC, Greet B, Orecchioni M, et al. In vivo restoration of myocardial conduction with carbon nanotube fibers. Circ Arrhythm Electrophysiol. 2019;12(8):e007256.
He Y, Ye G, Song C, Li C, Xiong W, Yu L, et al. Mussel-inspired conductive nanofibrous membranes repair myocardial infarction by enhancing cardiac function and revascularization. Theranostics. 2018;8(18):5159–77.
Doshi N, Swiston AJ, Gilbert JB, Alcaraz ML, Cohen RE, Rubner MF, et al. Cell-based drug delivery devices using phagocytosis-resistant backpacks. Adv Mater. 2011;23(12):H105–H9.
Klyachko NL, Polak R, Haney MJ, Zhao Y, Gomes Neto RJ, Hill MC, et al. Macrophages with cellular backpacks for targeted drug delivery to the brain. Biomaterials. 2017;140:79–87.
Zhao Y, Haney MJ, Mahajan V, Reiner BC, Dunaevsky A, Mosley RL, et al. Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson’s disease. J Nanomed Nanotechnol. 2011;S4.
Kumar A, Glaum M, El-Badri N, Mohapatra S, Haller E, Park S, et al. Initial observations of cell-mediated drug delivery to the deep lung. Cell Transplant. 2011;20(5):609–18.
Duarte-Sanmiguel S, Panic A, Dodd DJ, Salazar-Puerta A, Moore JT, Lawrence WR, et al. In situ deployment of engineered extracellular vesicles into the tumor niche via myeloid-derived suppressor cells. Adv Healthc Mater. 2021:e2101619.
Wang H, Yang Y, Liu J, Qian L. Direct cell reprogramming: approaches, mechanisms and progress. Nat Rev Mol Cell Biol. 2021;22(6):410–24.
Vierbuchen T, Wernig M. Direct lineage conversions: unnatural but useful? Nat Biotechnol. 2011;29(10):892–907.
Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268–77.
Evans CW, Fitzgerald M, Clemons TD, House MJ, Padman BS, Shaw JA, et al. Multimodal analysis of PEI-mediated endocytosis of nanoparticles in neural cells. ACS Nano. 2011;5(11):8640–8.
Wang M, Yu J, Cai L, Yang X. Direct reprogramming of mouse fibroblasts into hepatocyte-like cells by polyethyleneimine-modified nanoparticles through epigenetic activation of hepatic transcription factors. Mater Today Chem. 2020;17:100281.
Chang Y, Lee E, Kim J, Kwon Y-W, Kwon Y, Kim J. Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier. Biomaterials. 2019;192:500–9.
Muniyandi P, Palaninathan V, Mizuki T, Maekawa T, Hanajiri T, Mohamed MS. Poly(lactic-co-glycolic acid)/polyethylenimine nanocarriers for direct genetic reprogramming of microRNA targeting cardiac fibroblasts. ACS Appl Nano Mater. 2020;3(3):2491–505.
Yoo J, Lee E, Kim HY. Youn D-h, Jung J, Kim H, et al. Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson’s disease therapy. Nat Nanotechnol. 2017;12(10):1006–14.
Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng. 2014;16:295–320.
Gallego-Perez D, Pal D, Ghatak S, Malkoc V, Higuita-Castro N, Gnyawali S, et al. Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue. Nat Nanotechnol. 2017;12(10):974–9.
Zhao X, Huang X, Wang X, Wu Y, Eisfeld A-K, Schwind S, et al. Nanochannel electroporation as a platform for living cell interrogation in acute myeloid leukemia. Adv Sci. 2015;2(12):1500111.
Lemmerman LR, Balch MHH, Moore JT, Alzate-Correa D, Rincon-Benavides MA, Salazar-Puerta A, et al. Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke. Sci Adv. 2021;7(12):eabd4735.
Moore JT, Wier CG, Lemmerman LR, Ortega-Pineda L, Dodd DJ, Lawrence WR, et al. Nanochannel-based poration drives benign and effective nonviral gene delivery to peripheral nerve tissue. Adv Biosyst. 2020;4(11):2000157.
Boukany PE, Morss A, Liao WC, Henslee B, Jung H, Zhang X, et al. Nanochannel electroporation delivers precise amounts of biomolecules into living cells. Nat Nanotechnol. 2011;6(11):747–54.
Gallego-Perez D, Otero JJ, Czeisler C, Ma J, Ortiz C, Gygli P, et al. Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers. Nanomedicine. 2016;12(2):399–409.
Ortega-Pineda L, Sunyecz A, Salazar-Puerta AI, Rincon-Benavides MA, Alzate-Correa D, Anaparthi AL, et al. Designer extracellular vesicles modulate pro-neuronal cell responses and improve intracranial retention. Advanced Healthcare Materials.n/a(n/a):2100805.
Tang S, Salazar Puerta A, Richards J, Khan S, Hoyland J, Gallego-Perez D, et al. Non-viral reprogramming of human nucleus pulposus cells with FOXF1 via extracellular vesicle delivery: an in vitro and in vivo study. Eur Cell Mater. 2021;41:90–107.
Pigeau GM, Csaszar E, Dulgar-Tulloch A. Commercial scale manufacturing of allogeneic cell therapy. Front Med. 2018;5(233).
Nogueira DES, Cabral JMS, Rodrigues CAV. Single-use bioreactors for human pluripotent and adult stem cells: towards regenerative medicine applications. Bioengineering. 2021;8(5):68.
Sah J. Challenges of Stem Cell Therapy in Developing Country. J Stem Cell Res Ther. 2016;1:1–3.
Bryant J, Hlavaty KA, Zhang X, Yap W-T, Zhang L, Shea LD, et al. Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation. Biomaterials. 2014;35(31):8887–94.
Wilson JT, Chaikof EL. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev. 2008;60(2):124–45.
Cao Y, Ma E, Cestellos-Blanco S, Zhang B, Qiu R, Su Y, et al. Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules. Proc Natl Acad Sci. 2019;116(16):7899–904.
Xie X, Xu AM, Leal-Ortiz S, Cao Y, Garner CC, Melosh NA. Nanostraw–electroporation system for highly efficient intracellular delivery and transfection. ACS Nano. 2013;7(5):4351–8.
Vasdekis AE, Scott EA, O’Neil CP, Psaltis D, Hubbell JA. Precision intracellular delivery based on optofluidic polymersome rupture. ACS Nano. 2012;6(9):7850–7.
Joo J, Kwon EJ, Kang J, Skalak M, Anglin EJ, Mann AP, et al. Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain. Nanoscale Horizons. 2016;1(5):407–14.
Kwon EJ, Lasiene J, Jacobson BE, Park I-K, Horner PJ, Pun SH. Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone. Biomaterials. 2010;31(8):2417–24.
Moyer TJ, Kassam HA, Bahnson ESM, Morgan CE, Tantakitti F, Chew TL, et al. Shape-dependent targeting of injured blood vessels by peptide amphiphile supramolecular nanostructures. Small. 2015;11(23):2750–5.
Acknowledgements
Some illustrations were created using biorender.com.
Funding
Funding for this work was partly provided by the New Innovator Award DP2EB028110 (NIBIB/NIH), DP1DK126199 (NIDDK/NIH), and the Lisa Dean Moseley Foundation.
Author information
Authors and Affiliations
Contributions
The idea was conceived by DGP, DAC, and NHC. DGP, WL, and DAC oversaw the writing and editing of the main text, with input from all co-authors. ASP oversaw the creation of figures and figure legends.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Guest Editors: Aliasger Salem, Juliane Nguyen and Kristy Ainslie
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Alzate-Correa, D., Lawrence, W.R., Salazar-Puerta, A. et al. Nanotechnology-Driven Cell-Based Therapies in Regenerative Medicine. AAPS J 24, 43 (2022). https://doi.org/10.1208/s12248-022-00692-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12248-022-00692-3